RESEARCH ARTICLE
Effectiveness of Scraping and Mitomycin C to Treat Haze After Myopic Photorefractive Keratectomy
Leopoldo Spadea*, Valerio Verrecchia
Article Information
Identifiers and Pagination:
Year: 2011Volume: 5
First Page: 63
Last Page: 65
Publisher ID: TOOPHTJ-5-63
DOI: 10.2174/1874364101105010063
Article History:
Received Date: 24/3/2011Revision Received Date: 27/7/2011
Acceptance Date: 21/9/2011
Electronic publication date: 30/12/2011
Collection year: 2011

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
To report the possibility of post myopic photorefractive keratectomy (PRK) haze treatment in a patient with expressed reluctance for any additional laser therapy. Seven months after bilateral PRK with subsequent development of corneal haze and refractive regression in both eyes, a 37-old-year male patient presented a best-spectacle corrected visual acuity (BSCVA) of 20/30 in the right eye and of 20/22 in the left eye. Both eyes were sequentially treated by scraping the stromal surface and application of mitomycin C (MMC) for 2 minutes. Both eyes had significant improvement in corneal transparency. Eighteen months after this treatment BSCVA had improved to 20/20 in each eye. No toxic effects were observed during either re-epithelialization or follow-up periods. In conclusion scraping and application of MMC could be considered a good tool in the treatment of selected cases of haze after myopic PRK, especially with patients that are reluctant to undergo a secondary laser procedure.